Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors

September 2023

New bexagliflozin (Brenzavvy) will try to shake up the SGLT2 inhibitor market.

That’s because bexagliflozin will cost about $50/mo...versus about $600/mo for other SGLT2 inhibitors (dapagliflozin, etc).

But bexagliflozin won’t be covered by most payers yet...and it will only be available through a single online pharmacy at first. Expect distribution to broaden over the next couple months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Know What’s New for 2023-2024 Flu Immunizations
Vaccines Help Patients Age 60 and Over Decide About the RSV Vaccine
Depression Be Ready to Manage Treatment-Resistant Depression
Diabetes Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors
Dermatology Sort Through Options for Fungal Skin Infections
Pediatrics Be Familiar With Meds for Pediatric Type 2 Diabetes
Psychiatry Put Antipsychotics for Agitation in Dementia in Perspective
NatMed Spotlight Clarify the Effectiveness and Safety of Melatonin

Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents